VYGR A promising Biotech Play
In this difficult market , with China problems and trade wars on the surface , there are some uncorrelated with the market choices like some particular biotech stocks. Most of biotech is not for the fainthearted to say the least, but there are few names , which may reward handsomely the brave & knowledgeable investors. Our quantamental model indicates VYGR(Voyager Therapeutics) is such a case. Even though it has more than doubled the last 2 months and now is around 17.00 USD , there is still more room to run and our model gives a 75% chance to surpass 24 USD, the next 3-4 months for a greater than 40% gain. More conservative investors would be even more happy to be able to wait for a possible retracement to the 15 USD level.